LUNG NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation after surgery aims to stop lung Cancer's return
Disease control Not yet recruitingThis study is testing whether adding a precise form of radiation therapy after lung cancer surgery helps prevent the cancer from coming back. It will involve 164 adults who had surgery but still have cancer in nearby lymph nodes. Participants will be randomly assigned to receive …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New shot at stopping lung Cancer's return after surgery
Disease control Not yet recruitingThis study is testing whether giving an immunotherapy drug called atezolizumab after surgery can prevent early-stage non-small cell lung cancer from returning. It will compare patients who receive the drug for one year against those who receive standard follow-up care with observ…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Light beam targets stubborn lung tumors in new cancer trial
Disease control Not yet recruitingThis study is testing whether combining a light-activated drug with immunotherapy can help control advanced non-small cell lung cancer that hasn't responded to standard treatments. The treatment involves injecting a drug that becomes active when exposed to a special laser light, …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for Tough-to-Treat lung cancer: trial tests 'Smart Bomb' drug combo
Disease control Not yet recruitingThis study is testing whether combining two targeted drugs can help control advanced non-small cell lung cancer that has started growing again after standard treatment. The trial will enroll about 60 adults whose cancer has a specific genetic profile. One drug is a 'smart bomb' t…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Blood test could revolutionize lung cancer treatment timing
Disease control Not yet recruitingThis study aims to improve treatment for advanced non-small cell lung cancer by using blood tests to guide immunotherapy decisions. Researchers will track tumor DNA in the blood to determine when to continue, stop, or switch treatments. The goal is to develop personalized approac…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Spinal tap test could predict lung Cancer's spread to brain
Knowledge-focused Not yet recruitingThis study aims to see if a spinal fluid test can predict which patients with advanced lung cancer are likely to develop brain metastases. Researchers will collect spinal fluid and blood from 40 patients with stage III or IV non-small cell lung cancer, some with and some without …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC